Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,965 | 70 | 81.6% |
| Travel and Lodging | $666.94 | 4 | 18.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,438 | 41 | $0 (2021) |
| Nevro Corp. | $516.05 | 11 | $0 (2021) |
| Medtronic USA, Inc. | $387.45 | 11 | $0 (2020) |
| Boston Scientific Corporation | $111.11 | 2 | $0 (2019) |
| SI-BONE, INC. | $55.40 | 3 | $0 (2021) |
| Allergan, Inc. | $25.46 | 1 | $0 (2022) |
| ABBVIE INC. | $23.95 | 1 | $0 (2023) |
| Amgen Inc. | $23.15 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.20 | 1 | $0 (2022) |
| Avanos Medical | $17.14 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.95 | 1 | ABBVIE INC. ($23.95) |
| 2022 | $59.50 | 3 | Allergan, Inc. ($25.46) |
| 2021 | $198.01 | 7 | Abbott Laboratories ($112.21) |
| 2020 | $95.81 | 6 | Abbott Laboratories ($33.15) |
| 2019 | $1,267 | 27 | Nevro Corp. ($475.38) |
| 2018 | $1,988 | 30 | Abbott Laboratories ($1,867) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Gastroenterology | ||||||
| 10/31/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: NEUROLOGY | ||||||
| 02/23/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/21/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Neuromodulation | ||||||
| 11/04/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Neuroscience | ||||||
| 09/23/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 08/23/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 07/16/2021 | Abbott Laboratories | Penta SCS Leads (Device) | Food and Beverage | In-kind items and services | $94.01 | General |
| Category: Neuromodulation | ||||||
| 04/26/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/26/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/05/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/09/2020 | Avanos Medical | GENERATOR (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/17/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/17/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/05/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/03/2020 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 12/02/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $129.28 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/21/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/12/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/06/2019 | Medtronic USA, Inc. | VECTRIS (Device) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/16/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/09/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/09/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/04/2019 | Medtronic USA, Inc. | VECTRIS (Device) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,038 | 1,175 | $441,022 | $77,509 |
| 2022 | 24 | 3,194 | 7,093 | $2.3M | $371,362 |
| 2021 | 29 | 2,165 | 4,221 | $1.1M | $211,035 |
| 2020 | 20 | 1,045 | 2,521 | $387,949 | $122,880 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 379 | $121,280 | $24,106 | 19.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 168 | 171 | $126,198 | $19,155 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 335 | 393 | $96,678 | $18,294 | 18.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 179 | 182 | $74,620 | $11,075 | 14.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 19 | 19 | $14,706 | $3,701 | 25.2% |
| 01996 | Daily hospital management of continuous spinal drug administration | Facility | 2023 | 15 | 15 | $4,500 | $723.90 | 16.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $3,040 | $454.74 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 645 | 1,205 | $385,600 | $104,778 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 612 | 1,131 | $278,226 | $67,011 | 24.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 460 | 582 | $429,516 | $64,693 | 15.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 521 | 659 | $270,190 | $39,643 | 14.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 104 | 104 | $80,496 | $19,650 | 24.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 36 | 50 | $82,656 | $18,294 | 22.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 36 | 59 | $183,680 | $10,777 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $34,850 | $10,014 | 28.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 34 | 49 | $39,360 | $8,907 | 22.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 44 | 57 | $99,712 | $7,509 | 7.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 34 | 56 | $69,536 | $5,518 | 7.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 69 | $13,110 | $2,831 | 21.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 25 | 33 | $10,824 | $2,503 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $9,610 | $2,467 | 25.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 12 | 17 | $32,300 | $2,461 | 7.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 29 | 62 | $30,504 | $2,437 | 8.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 17 | 22 | $4,680 | $1,029 | 22.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 104 | 104 | $1,560 | $328.56 | 21.1% |
About Dr. Jerrod Mccarty, MD
Dr. Jerrod Mccarty, MD is a Anesthesiology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2014. The National Provider Identifier (NPI) number assigned to this provider is 1922414911.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerrod Mccarty, MD has received a total of $3,632 in payments from pharmaceutical and medical device companies, with $23.95 received in 2023. These payments were reported across 74 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,965).
As a Medicare-enrolled provider, Mccarty has provided services to 7,442 Medicare beneficiaries, totaling 15,010 services with total Medicare billing of $782,786. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Lexington, KY
- Active Since 07/10/2014
- Last Updated 12/13/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1922414911
Products in Payments
- Proclaim Family of SCS IPGs (Device) $1,232
- Neuromodulation Dspsbls and Accs (Device) $1,094
- Senza Spinal Cord Stimulation System (Device) $487.48
- INTELLIS (Device) $227.56
- VECTRIS (Device) $159.89
- GENERAL PAIN MANAGEMENT (Device) $98.74
- Penta SCS Leads (Device) $94.01
- BOTOX (Biological) $49.41
- IFUSE IMPLANT (Device) $34.08
- Omnia (Device) $28.57
- Aimovig (Biological) $23.15
- iFuse Implant (Device) $21.32
- RELISTOR (Drug) $20.20
- Proclaim IPG (Device) $18.20
- GENERATOR (Device) $17.14
- VYEPTI (Biological) $13.84
- GENERAL PAIN MANAGEMENT (Device) $12.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Lexington
Paula Bokesch, M.d, M.D
Anesthesiology — Payments: $573,750
Jay Grider, Do, Phd, DO, PHD
Anesthesiology — Payments: $86,023
Dr. Christopher Mallard, M.d, M.D
Anesthesiology — Payments: $33,044
Balachundhar Subramaniam, M.b.b.s, M.d, M.B.B.S, M.D
Anesthesiology — Payments: $22,896
Oliver James, M.d, M.D
Anesthesiology — Payments: $21,274
Dr. Shawn Milburn, Md, MD
Anesthesiology — Payments: $13,577